The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality

被引:72
|
作者
Theodoratou, Evropi
Johnson, Sue
Jhass, Arnoupe
Madhi, Shabir A. [2 ]
Clark, Andrew [3 ]
Boschi-Pinto, Cynthia [4 ]
Bhopa, Sunil [5 ]
Rudan, Igor [6 ]
Campbell, Harry [1 ]
机构
[1] Univ Edinburgh, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland
[2] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa
[3] London Sch Hyg & Trop Med, London WC1, England
[4] WHO, CH-1211 Geneva, Switzerland
[5] Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England
[6] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia
基金
比尔及梅琳达.盖茨基金会;
关键词
childhood pneumonia; pneumococcal conjugate vaccine; Haemophilus influenzae type b vaccine; developing countries; RADIOLOGICALLY-CONFIRMED PNEUMONIA; PLACEBO-CONTROLLED-TRIAL; STREPTOCOCCUS-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; NONVACCINE SEROTYPES; CHILDREN YOUNGER; OTITIS-MEDIA; DOUBLE-BLIND; HIB DISEASE; BURDEN;
D O I
10.1093/ije/dyq033
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background With the aim of populating the Lives Saved Tool (LiST) with parameters of effectiveness of existing interventions, we conducted a systematic review of the literature assessing the effect of Haemophilus influenzae type b (Hib) and pneumococcal (PC) conjugate vaccines on incidence, severe morbidity and mortality from childhood pneumonia. Methods We summarized cluster randomized controlled trials (cRCTs) and case control studies of Hib conjugate vaccines and RCTs of 9- and 11-valent PC conjugate vaccines conducted in developing countries across outcome measures using standard meta-analysis methods. We used a set of standardized rules developed for the purpose of populating the LiST tool with required parameters to promote comparability across reviews of interventions against the major causes of childhood mortality. The estimates could be adjusted further to account for factors such as PC vaccine serotype content, PC serotype distribution and human immunodeficiency virus prevalence but this was not included as part of the LIST model approach. Results The available evidence from published data points to a summary effect of the Hib conjugate vaccine on clinical pneumonia of 4%, on clinical severe pneumonia of 6% and on radiologically confirmed pneumonia of 18%. Respective effectiveness estimates for PC vaccines (all valent) on clinical pneumonia is 7%, clinical severe pneumonia is 7% and radiologically confirmed pneumonia is 26%. Conclusions The findings indicated that radiologically confirmed pneumonia, as a severe morbidity proxy for mortality, provided better estimates for the LiST model of effect of interventions on mortality reduction than did other outcomes evaluated. The LiST model will use this to estimate the pneumonia mortality reduction which might be observed when scaling up Hib and PC conjugate vaccination in the context of an overall package of child health interventions.
引用
收藏
页码:172 / 185
页数:14
相关论文
共 50 条
  • [41] An animal model to evaluate the protective efficacy of Haemophilus influenzae type b conjugate vaccines
    Kim, HS
    Yoo, TH
    Jang, YS
    Kim, H
    Park, JY
    Hur, BK
    Ryu, YW
    Kim, JS
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2004, 9 (06) : 490 - 494
  • [42] Ten years' experience with Haemophilus influenzae type b (Hib) conjugate vaccines in Finland
    Eskola, Juhani
    Käyhty, Helena
    International Journal of General Systems, 2002, 31 (01) : 231 - 241
  • [43] Efficacy of Haemophilus influenzae type b conjugate vaccines and persistence of disease in disadvantaged populations
    Jafari, HS
    Adams, WG
    Robinson, KA
    Plikaytis, BD
    Wenger, JD
    AMERICAN JOURNAL OF PUBLIC HEALTH, 1999, 89 (03) : 364 - 368
  • [44] RAPID DISAPPEARANCE OF HAEMOPHILUS-INFLUENZAE TYPE-B MENINGITIS AFTER ROUTINE CHILDHOOD IMMUNIZATION WITH CONJUGATE VACCINES
    PELTOLA, H
    KILPI, T
    ANTTILA, M
    LANCET, 1992, 340 (8819): : 592 - 594
  • [45] CLINICAL-EXPERIENCE WITH HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINES
    MAKELA, PH
    ESKOLA, J
    PELTOLA, H
    TAKALA, AK
    KAYHTY, H
    PEDIATRICS, 1990, 85 (04) : 651 - 653
  • [46] Development and technology transfer of Haemophilus influenzae type b conjugate vaccines for developing countries
    Beurret, Michel
    Hamidi, Ahd
    Kreeftenberg, Hans
    VACCINE, 2012, 30 (33) : 4897 - 4906
  • [47] Incidence of Haemophilus influenzae Type b Disease in The Gambia 14 Years after Introduction of Routine Haemophilus influenzae Type b Conjugate Vaccine Immunization
    Oluwalana, Claire
    Howie, Stephen R. C.
    Secka, Ousman
    Ideh, Readon C.
    Ebruke, Bernard
    Sambou, Sana
    Erskine, James
    Lowe, Yamundow
    Corrah, Tumani
    Adegbola, Richard A.
    JOURNAL OF PEDIATRICS, 2013, 163 (01): : S4 - S7
  • [48] Establishment of childhood pneumonia cause in the era of pneumococcal conjugate vaccines
    Rhedin, Samuel
    LANCET RESPIRATORY MEDICINE, 2016, 4 (06): : 423 - 424
  • [49] The incidence of pediatric invasive Haemophilus influenzae and pneumococcal disease in Chiba prefecture, Japan before and after the introduction of conjugate vaccines
    Ishiwada, Naruhiko
    Hishiki, Haruka
    Nagasawa, Koo
    Naito, Sachiko
    Sato, Yasunori
    Chang, Bin
    Sasaki, Yuko
    Kimura, Kouji
    Ohnishi, Makoto
    Shibayama, Keigo
    VACCINE, 2014, 32 (42) : 5425 - 5431
  • [50] Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses
    Constenla, D.
    Liu, T.
    VACCINE, 2019, 37 (52) : 7547 - 7559